Fresenius | FRE - Себестоимость





Себестоимость Изменить Дата
Akzo Nobel EUR 1.5B 95M 2026-06
Alcon AG USD 1.12B 61M 2026-06
AstraZeneca USD 2.52B 2.73B 2026-06
BASF EUR 12.87B 1.01B 2026-06
Bayer EUR 4.54B 692M 2026-06
Beiersdorf EUR 2.06B 50M 2025-12
DaVita Healthcare Partners USD 2.39B 128.08M 2026-06
Demant DKK 2.96B 61M 2026-06
E.ON EUR 12.83B 3.58B 2026-06
Essilor EUR 5.55B 505M 2026-06
Fresenius EUR 4.4B 111M 2026-06
Fresenius Medical Care EUR 3.55B 117.58M 2026-06
Getinge SEK 3.97B 2.05B 2026-06
Givaudan CHF 2.07B 105M 2025-12
GlaxoSmithKline GBP 2.07B 192M 2026-06
GN Store Nord DKK 1.09B 67M 2026-06
GRIFOLS EUR 1.17B 90M 2026-06
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Lonza CHF 2.28B 189M 2025-06
Merck EUR 2.27B 199M 2026-06
Novartis USD 3.71B 251M 2026-06
Philips EUR 2.21B 70M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
RWE EUR 3.15B 60M 2026-06
Sanofi EUR 3.02B 656M 2026-06
Smith & Nephew USD 901M 31M 2026-06